Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Bimatoprost 1% Formulation A · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| All Participants | EXPERIMENTAL | Bimatoprost 1% Formulation A solution applied to the left side of the scalp and trunk area and Bimatoprost 1% Formulation B solution applied to the right side of the scalp and trunk area once daily for 14 days. |
| Name | Type | Description |
|---|---|---|
| Bimatoprost 1% Formulation A | DRUG | Bimatoprost 1% Formulation A solution applied to the scalp and trunk once daily for 14 days. |
| Bimatoprost 1% Formulation B | DRUG | Bimatoprost 1% Formulation B solution applied to the scalp and trunk once daily for 14 days. |
Inclusion Criteria: -Patients with mild to moderate Androgenetic Alopecia of the vertex area of the scalp. Exclusion Criteria: * Patients with uncontrolled systemic disease * History of significant cardiovascular disease * Scarring disease, infection, or abnormality of the scalp or hair shaft or ...
Bimatoprost 1% Formulation A is an investigational small molecule being developed for androgenetic alopecia, a common form of hair loss. It is applied to the scalp and is currently in Phase 1 clinical development.
Bimatoprost 1% Formulation A is being developed by AbbVie Inc., a biopharmaceutical company traded on the New York Stock Exchange under the ticker ABBV.
Bimatoprost 1% Formulation A is in Phase 1 clinical development. It is an investigational drug and has not been approved by the FDA. One Phase 1 trial has been completed.
Bimatoprost 1% Formulation A has one completed Phase 1 trial, NCT02848300, which studied local pharmacokinetics and tolerability of the drug applied to the scalp in male patients with androgenetic alopecia. The trial enrolled 11 participants in the United States.
Bimatoprost 1% Formulation A is a specific formulation of bimatoprost, a small molecule. It is being studied for androgenetic alopecia, whereas bimatoprost is also known for other uses. The 1% formulation is distinct in its concentration and application.